This is a data case study with interactive price comparison charts. View the full interactive version →
How I Built This
Sources. RAND Hospital Price Transparency Study (4th edition, 2022) for hospital-vs-Medicare price ratios; OECD Health Statistics 2022 for per-capita spending; Himmelstein et al. (NEJM, 2020) for administrative overhead; Patient Rights Advocate reports for compliance rates; CFPB (2022) and KFF polling for medical debt.
Method. Cross-country prices aren't directly comparable procedure-by-procedure, so I use two normalizations: (1) Medicare multiples — expressing each hospital's negotiated rates as a percentage of what Medicare pays for the identical procedure code, which is RAND's method and controls for procedure mix; and (2) per-capita spending ratios for the international view. The "2.35× above global benchmarks" headline is US per-capita spending ($12,555) divided by the average of five peer systems (UK, Germany, Canada, Japan, Australia — ~$5,350). Those are two different lenses; the 224%-of-Medicare figure is about price, the 2.35× figure is about total spending — I keep them separate because conflating them is how healthcare statistics usually go wrong.
Assumptions & limits. Hospital-published transparency files are inconsistent enough that RAND's employer-claims sample remains more reliable than the raw CMS files; per-capita comparisons bundle price, utilisation, and demographics, so the 2.35× is a system-level gap, not a pure price gap; debt figures are self-reported survey data with the usual biases.
The Most Expensive Healthcare System That Isn't the Healthiest
The United States spends $12,555 per person per year on healthcare (OECD 2022). The UK, operating a single-payer National Health Service, spends $3,795 — less than a third — and achieves comparable or better outcomes across most indicators (Commonwealth Fund Mirror on the Wall 2023).
The gap isn't explained by better outcomes, higher-quality care, or more services. It is explained, substantially, by price: American hospitals charge more for the same procedures than any comparable healthcare system in the world.
The RAND Numbers
RAND's Hospital Price Transparency Study (4th edition, 2022) is the most comprehensive analysis of US hospital pricing ever published. It surveyed prices at over 4,000 hospitals and found:
- Hospitals charge private insurers, on average, 224% of what Medicare pays for the same procedure
- The highest-charging 10% of hospitals charge over 400% of Medicare rates
- For the same procedure, prices at different hospitals in the same city routinely vary by 3–10×
- A caesarean section ranges from $6,241 to $60,584 across hospitals — for identical medical complexity
These aren't billing quirks. They are the direct result of opaque, privately negotiated rates between hospitals and insurers — rates that patients have historically had no right to see.
31% on Administration Alone
Himmelstein et al. (2020, NEJM) found that 31% of US healthcare spending — roughly $812 billion annually — goes to billing and administrative overhead. In Canada's single-payer system, the equivalent figure is 12%.
The difference is not complexity of care. It is the cost of running a system where each insurer negotiates thousands of custom rates with thousands of hospitals, generates hundreds of millions of explanation-of-benefits documents, and employs armies of claims processors on both sides of the transaction.
The Price Transparency Rule: What Changed
In 2021, CMS required all US hospitals to publish machine-readable files disclosing their prices — including negotiated rates with each insurer. The rule was significant: for the first time, the data legally had to exist.
In practice:
- As of mid-2023, ~70% of hospitals had posted files — but many were non-standard, missing key fields, or gigabytes in size requiring technical expertise to parse
- A 2023 Patient Rights Advocate analysis found only ~36% fully compliant with CMS specifications
- Initial penalties ($300/day, capped at $109,500/yr) were trivially small for major health systems; CMS raised these to up to $2M/year in 2022 for larger hospitals
Peterson-KFF analysis found that price transparency tools, as implemented, had not measurably changed patient shopping behaviour — partly because patients aren't the decision-makers during emergencies, and partly because the files are practically inaccessible to non-specialists.
The Medical Debt Crisis
100 million Americans carry medical debt (CFPB 2022). Total outstanding medical debt is $88 billion. Medical debt is the leading cause of personal bankruptcy in the US — a distinction no other wealthy country shares.
KFF/Washington Post polling (2022) found that 41% of adults reported having medical debt, and 1 in 7 had been denied care because of an unpaid medical bill.
What the Interactive Case Study Shows
The full case study includes:
- A procedure price comparison tool: input any common procedure and see the actual range of prices charged across hospitals
- The global spending comparison chart: US vs. UK, Germany, Canada, Japan, and Australia
- A breakdown of administrative overhead vs. clinical spending
- The compliance tracker for the price transparency rule
The Analyst's Takeaway
The data says the binding constraint isn't information — it's incentives. Transparency files exist and haven't moved patient behaviour, because patients don't choose hospitals mid-emergency and can't parse gigabyte JSON files. If I were analysing this for a payer or policy team, the actionable levers in the data are: (1) reference pricing tied to Medicare multiples, which directly targets the 224% wedge; and (2) penalty structures indexed to hospital revenue rather than flat caps, since the compliance data shows flat penalties priced non-compliance as a cheap licence. The 3–10× same-city price spread is the clearest signal in the dataset that this is a negotiation-power problem, not a cost-of-care problem.
Explore the full interactive case study — price comparisons, debt data, and policy analysis →